Abstract
Adequate presentation of risks and benefits of medical therapies is essential to informed decision making by patients. Transcatheter aortic valve replacement (TAVR) has been recently approved by the US Food and Drug Administration for the treatment of severe aortic stenosis among carefully selected patients; recent randomized clinical trials have identified important positive and negative outcomes of TAVR in these populations, including twice the risk of stroke for patients undergoing TAVR vs those undergoing open aortic valve replacement.(,) Since 78% of all adults in the United States seek out health information online,we assessed the information regarding known risks and benefits of TAVR made available to the public on the websites of US hospitals currently performing TAVR procedures.